Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 31-40 of 45 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2009Reduction of opioid withdrawal and potentiation of acute opioid analgesia by systemic AV411 (ibudilast)Hutchinson, M.; Lewis, S.; Coats, B.; Skyba, D.; Crysdale, N.; Berkelhammer, D.; Brzeski, A.; Northcutt, A.; Vietz, C.; Judd, C.; Maier, S.; Watkins, L.; Johnson, K.
2007'Listening' and 'talking' to neurons: Implications of immune activation for pain control and increasing the efficacy of opioidsWatkins, L.; Hutchinson, M.; Milligan, E.; Maier, S.
2010A novel animal model of graded neuropathic pain: Utility to investigate mechanisms of population heterogeneityGrace, P.; Hutchinson, M.; Manavis, J.; Somogyi, A.; Rolan, P.
2010Application of a novel in silico high-throughput screen to identify selective inhibitors for protein-protein interactionsJoce, C.; Stahl, J.; Shridhar, M.; Hutchinson, M.; Watkins, L.; Fedichev, P.; Yin, H.
2011Attenuating glial activation with minocycline reduces the hyperthermic response to 3, 4-methylenedioxymethamphetamine (MDMA) in the ratAnderson, P.; Hutchinson, M.; Irvine, R.; Salem, A.
2009A Peptide Antagonist of the TLR4-MD2 InteractionSlivka, P.; Shridhar, M.; Lee, G.; Sammond, D.; Hutchinson, M.; Martinko, A.; Buchanan, M.; Sholar, P.; Kearney, J.; Harrison, J.; Watkins, L.; Yin, H.
2012Implications of central immune signaling caused by drugs of abuse: Mechanisms, mediators and new therapeutic approaches for prediction and treatment of drug dependenceColler, J.; Hutchinson, M.
2009The cortical innate immune response increases local neuronal excitability leading to seizuresRodgers, K.; Hutchinson, M.; Northcutt, A.; Maier, S.; Watkins, L.; Barth, D.
2011Exploring the neuroimmunopharmacology of opioids: An integrative review of mechanisms of central immune signaling and their implications for opioid analgesiaHutchinson, M.; Shavit, Y.; Grace, P.; Rice, K.; Maier, S.; Watkins, L.
2010Evidence that opioids may have toll-like receptor 4 and MD-2 effectsHutchinson, M.; Zhang, Y.; Shridhar, M.; Evans, J.; Buchanan, M.; Zhao, T.; Slivka, P.; Coats, B.; Rezvani, N.; Wieseler-Frank, J.; Hughes, T.; Landgraf, K.; Chan, S.; Fong, S.; Phipps, S.; Falke, J.; Maier, S.; Leinwand, L.; Yin, H.; Rice, K.; et al.